XML 275 R100.htm IDEA: XBRL DOCUMENT v3.25.2
Remeasurement items affecting operating profit (Details)
R in Millions
12 Months Ended
Jun. 30, 2025
ZAR (R)
MT / yr
R / $
Jun. 30, 2025
ZAR (R)
MT / yr
R / $
Jun. 30, 2024
ZAR (R)
Jun. 30, 2023
ZAR (R)
MT / yr
MW
Jun. 30, 2018
ZAR (R)
Dec. 31, 2050
$ / T
Dec. 31, 2030
Remeasurement items              
Targeted reduction of greenhouse gas (GHG) emission by 2030 30.00% 30.00%          
Escalated tax rates for Scope 1 GHG emissions | $ / T           55  
Increase (decrease) in basic tax free emission allowance for every five years             (3.00%)
Impairment loss (reversal of impairment loss)   R 20,658 R 74,886 R 33,649      
Secunda liquid fuels refinery | Fuels              
Remeasurement items              
Targeted production volumes assumed by emission reduction roadmap in 2030 | MT / yr 7 7   6.7      
Targeted production volumes assumed by emission reduction roadmap from 2034 | MT / yr 6.4 6.4          
Increase (decrease) in price of Brent crude for impairment calculations 10.00% 10.00%          
Increase (decrease) in recoverable amount of CGU due to change in the price of Brent crude R 26,000 R 26,000          
Increase (decrease) in exchange rate for impairment calculations | R / $ (1) (1)          
Increase (decrease) in recoverable amount of CGU due to change in exchange rate R 17,200 R 17,200          
Increase (decrease) in volumes for impairment calculations 1.00% 1.00%          
Increase (decrease) in recoverable amount of CGU due to change in volumes R 1,285 R 1,285          
Weighted average cost of capital for impairment calculations 14.50% 14.50%          
Targeted reduction of greenhouse gas (GHG) emission by 2030       30.00%      
Targeted integrating of renewable energy into operations by 2030 | MW       1,200      
Impairment loss (reversal of impairment loss)   R 11,831 7,803 R 35,316      
Sasolburg liquid fuels refinery | Fuels              
Remeasurement items              
Weighted average cost of capital for impairment calculations 14.50% 14.50%          
Impairment loss (reversal of impairment loss)   R 1,256 637        
Production Sharing Agreement (PSA) | Gas              
Remeasurement items              
Increase (decrease) in estimated gas volumes   (3.00%)          
Increase in WACC for impairment calculations 1.00% 1.00%          
Increase (decrease) in value in use due to increase in WACC R (460) R (460)          
Decrease in WACC for impairment calculations (1.00%) (1.00%)          
Increase (decrease) in value in use due to decrease in WACC R 499 R 499          
Increase in volumes for impairment calculations 5.00% 5.00%          
Increase (decrease) in recoverable amount of CGU due to increase in volumes R 1,142 R 1,142          
Decrease in volumes for impairment calculations (5.00%) (5.00%)          
Increase (decrease) in recoverable amount of CGU due to decrease in volumes R (1,121) R (1,121)          
Recoverable amount R 15,600 15,600          
Impairment loss (reversal of impairment loss)   3,142 (1,143)   R 1,100    
Polyethylene | Chemicals Africa              
Remeasurement items              
Impairment loss (reversal of impairment loss)     4,110        
Sasolburg Chlor-Alkali and PVC | Chemicals Africa              
Remeasurement items              
Impairment loss (reversal of impairment loss)   463 645        
Sasolburg Wax | Chemicals Africa              
Remeasurement items              
Weighted average cost of capital for impairment calculations       14.66%      
Impairment loss (reversal of impairment loss)   364 524 R 932      
Ethane value chain (Alc/Alu/EO/EG) | Chemicals America              
Remeasurement items              
Impairment loss (reversal of impairment loss)     58,942        
Sasol Italy Care Chemicals (CC) | Chemicals Eurasia              
Remeasurement items              
Impairment loss (reversal of impairment loss)   R 3,258 2,037        
Sasol China Care Chemicals (CC) | Chemicals Eurasia              
Remeasurement items              
Number of years of projections of volume and earnings were met 2 years            
Weighted average cost of capital for impairment calculations 9.90% 9.90%   9.21%      
Recoverable amount R 3,200 R 3,200          
Impairment loss (reversal of impairment loss)   (1,168)   R 876      
Tetramerization | Chemicals America              
Remeasurement items              
Weighted average cost of capital for impairment calculations       8.33%      
Impairment loss (reversal of impairment loss)       R (3,645)      
Other (net)              
Remeasurement items              
Impairment loss (reversal of impairment loss)   R 270 R 1,331 R 170